Announcements Trials

Browse Landscape

Status

Completed 7 Terminated 3 Recruiting 3 Unknown 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Lung Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Recurrence 2 Neoplasm Metastasis 2 Malignant Neoplasms of Independent (Primary) Multiple Sites 2 Lung Diseases 2 Head and Neck Neoplasms 2 cyclopia sequence 1 Tobacco Use Cessation 1 Smoke Inhalation Injury 1 Sezary Syndrome 1 Seroma 1 Sarcoma 1 Respiratory Aspiration 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyneuropathies 1 Peripheral Nervous System Diseases 1 Patient Education 1 Pain 1 Ovarian Neoplasms 1 Occupational Stress 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Mesothelioma 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Rituximab 20 Cyclophosphamide 18 Etoposide 11 Vincristine 10 Doxorubicin 10 fludarabine phosphate 9 Prednisone 9 Filgrastim 9 Radiotherapy 8 Peripheral Blood Stem Cell Transplantation 8 Cytarabine 8 Methotrexate 7 Melphalan 7 Dexamethasone 6 fludarabine 4 Cyclosporine 4 Antilymphocyte Serum 4 duvelisib 3 belinostat 3 Thiotepa 3 Tacrolimus 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Ifosfamide 3 Gemcitabine 3 Carmustine 3 Busulfan 3 Alemtuzumab 3 sargramostim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphoma × Surveys and Questionnaires × Clear all

NCT00488553 2012-02-24

Molecular Epidemiology of Lymphoma Patients

M.D. Anderson Cancer Center

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡